Review
Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art
Affiliations
- PMID: 9218984
Item in Clipboard
Review
Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art
Funct Neurol.
1997 May-Aug.
No abstract available
Similar articles
-
[Nootropic drugs: definition, classification, mechanism of action, clinical effectiveness, substances].Z Arztl Fortbild (Jena). 1994 Sep;88(9):697-701. Z Arztl Fortbild (Jena). 1994. PMID: 7975756 Review. German. No abstract available.
-
[Possibilities and limits of therapy of cognition disorders in the elderly].Z Gerontol Geriatr. 1995 Nov-Dec;28(6):457-62. Z Gerontol Geriatr. 1995. PMID: 8581765 Review. German.
-
Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.Clin Geriatr Med. 2004 Feb;20(1):59-68. doi: 10.1016/j.cger.2003.11.002. Clin Geriatr Med. 2004. PMID: 15062487 No abstract available.
-
Galantamine for Alzheimer's disease and mild cognitive impairment.Neuroepidemiology. 2007;28(2):116-7. doi: 10.1159/000101510. Epub 2007 Apr 4. Neuroepidemiology. 2007. PMID: 17409773 No abstract available.
-
[Challenging pharmacotherapy in dementia].MMW Fortschr Med. 2009 Mar 26;151(13):46-8. MMW Fortschr Med. 2009. PMID: 19504818 German. No abstract available.
Cited by
-
Therapeutic use of nicergoline.Clin Drug Investig. 2008;28(9):533-52. doi: 10.2165/00044011-200828090-00001. Clin Drug Investig. 2008. PMID: 18666801 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical